跳至主要内容
临床试验/JPRN-jRCTs051190046
JPRN-jRCTs051190046已完成2 期

Efficacy of Pediococcus acidilactoci K15 strain on allergic symptoms related to Japanese cedar pollinosis induced by artificial exposure: A randomised placebo-controlled trial

Yamamoto Masashi0 个研究点目标入组 30 人开始时间: 2019年9月6日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

In K-15 lactic acid bacteria group, improvement of symptoms (especially nasal symptoms) was observed. There was no problem with safety and the continuity was godd.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 64age old(—)
性别
All

入选标准

  • 1.individuals aged from 20 to 64 who will give informed consent upon their will
  • 2.individuals who had allergic symptoms such as sneezing, rhinorrhea, nasal obstruction and eye itching during Japanese cedar pollen dispersal season in the past two consecutive years
  • 3.individuals who show positive IgE titer more than class II for Japanese cedar pollen by RAST

排除标准

  • 1.individuals receiving allergen (Japanese cedar pollen) immunotherapy or those who will receive allergen immunotherapy during the study
  • 2.individuals with active diseases and judged to be inappropriate to join the study by their primary care physicians
  • 3.individuals who are pregnant and brest-feeding or will have a plan of pregnancy during the study
  • 4.individuals who habitually intake prebiotics or probiotics (more than 3 days in a week)
  • 5.individuals who join other clinical studies
  • 6.individuals who take anti-allergic drugs before or during the study

研究者

发起方
Yamamoto Masashi

相似试验